DF/HCC Program Affiliation

Reduction of Cancer Risk and Disparities

Research Abstract

Dennis Ross-Degnan, ScD, Associate Professor and Harvard Pilgrim Health Care Director of Research, is a health services researcher with a doctorate in health policy and management. He is also co-Director of a World Health Organization Collaborating Center on Pharmaceutical Policy and a member of the Dana Farber-Harvard Cancer Center Risk Reduction Core. He coordinates data management and analyses for the Drug Policy Research Group’s large database research studies and leads the DPRG’s qualitative research portfolio. Dr. Ross-Degnan’s research focuses on the effects of pharmaceutical policies, factors underlying appropriate use of medicines, and interventions to change the practices of health providers. He has developed and tested many behaviorally-focused interventions to improve quality of care and translate clinical best practice to defined populations, both in the United States and in many developing countries. He also leads work on disparities in access to medical care by minority populations.

Publications

• Ross-Degnan D, Simoni-Wastila L, Brown JS, Gao X, Mah C, Cosler LE, Fanning T, Gallagher P, Salzman C, Shader RI, Inui TS, Soumerai SB.A controlled study of the effects of state surveillance on indicators of problematic and non-problematic benzodiazepine
  15387395
• Soumerai SB, Mah C, Zhang F, Adams A, Barton M, Fajtova V, Ross-Degnan D.Effects of health maintenance organization coverage of self-monitoring devices on diabetes self-care and glycemic control.Arch Intern Med 2004 Mar 22;164(6):645-52.
  15037493